NCT03692104View on ClinicalTrials.gov

US-CT Fusion for Post Implant Dosimetry

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

December 31, 2019

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

transrectal ultrasound

Use of US for post implant quality assessment

Trial Locations (1)

V1Y5L3

BC Cancer, Kelowna

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER

NCT03692104 - US-CT Fusion for Post Implant Dosimetry | Biotech Hunter | Biotech Hunter